Genmab A (GMAB) Long-Term Investments (2023 - 2025)

Genmab A's Long-Term Investments history spans 3 years, with the latest figure at $37.0 million for Q4 2025.

  • For Q4 2025, Long-Term Investments rose 15.62% year-over-year to $37.0 million; the TTM value through Dec 2025 reached $37.0 million, up 15.62%, while the annual FY2025 figure was $37.0 million, 15.62% up from the prior year.
  • Long-Term Investments reached $37.0 million in Q4 2025 per GMAB's latest filing, up from $32.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $37.0 million in Q4 2025 to a low of $20.0 million in Q4 2023.
  • Average Long-Term Investments over 3 years is $29.7 million, with a median of $32.0 million recorded in 2024.
  • Peak YoY movement for Long-Term Investments: soared 60.0% in 2024, then grew 15.62% in 2025.
  • A 3-year view of Long-Term Investments shows it stood at $20.0 million in 2023, then surged by 60.0% to $32.0 million in 2024, then increased by 15.62% to $37.0 million in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Long-Term Investments are $37.0 million (Q4 2025), $32.0 million (Q4 2024), and $20.0 million (Q4 2023).